Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery;Topikal uygulanan aprotinin ve traneksamik asitin açik kalp cerrahisi sonrasi kan kaybina etkisi

Anadolu Kardiyoloji Dergisi

Volumn 5, Issue 1, 2005, Pages 36-40

  Yasim, Alptekin ^b,c   Aşik, Ramazan ^b   Atahan, Erhan ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b Kayseri Devlet Hastanesi   (Turkey)

^c NONE   (Turkey)

Author keywords

Aprotinin; Open heart surgery; Postoperative bleeding; Tranexamic acid

Indexed keywords

APROTININ; PLACEBO; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEDICAL DOCUMENTATION; OPEN HEART SURGERY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; STERNOTOMY; TREATMENT OUTCOME; WOUND CLOSURE;

ADMINISTRATION, CUTANEOUS; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 14944382014     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tatar H, Çiçek S, Demirkiliç U, et al. Topical use of aprotinin in open heart operation. Ann Thorac Surg 1993; 55: 659-61.
2. De Bonis M, Cavaliere F, Alessandrini F, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double - blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 2000; 119: 575-80.
3. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Paramo JA. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation 1994; 90: 921-7.
4. Casati V, Guzzon D, Oppizzi M, et al. Tranexamic acid compared with high - dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogenic transfusions. J Thorac Cardiovasc Surg 2000; 120: 520-7.
5. Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993; 106: 11-8.
6. Casati V, Bellotti F, Gerli C, et al. Tranexamic acid administration after cardiac surgery. Anesthesiology 2001; 94: 8-14.
7. Jamieson WRE, Dryden PJ, O'Connor JP, Sadeghi H, Ansley DM, Merrick PM. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. Circulation 1997; 96 (suppl): 1196-101.
8. Mongan PD, Brown RS, Thwaites BK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusion during primary coronary revascularization. Anesth Analg 1998; 87: 258-65.
9. Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations. J Thorac Cardiovasc Surg 1997; 113: 802-4.
10. Casati V, Sandrelli L, Speziali G, Calori G, Grasso MA, Spagnola S. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 2002; 123: 1084-91.
11. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971-6.
12. O'Regan DJ, Giannopoulos N, Mediratta N, et al. Topical aprotinin in cardiac operations. Ann Thorac Surg 1994; 58: 778-81.
13. Lemmer JH, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994; 107: 543-53.
14. Kalangos A, Tayyareci G, Pretre R, Di Dio P, Sezerman O. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization. Eur J Cardiothorac Surg 1994; 8: 651-6.
15. Nuttal GA, Fass ON, Oyen LJ, Oliver WC, Ereth MH. A study of a weight - adjusted aprotinin dosing schedule during cardiac surgery. Anesth Analg 2002; 94: 283-9.
16. Hayashida N, Isomura T, Sato T, Maruyama H, Kosuga K, Aoyagi S. Effects of minimal - dose aprotinin on coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 114: 261-9.
17. De Peppo AP, Pierri MD, Scafuri A, et al. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Tex Heart Inst J 1995; 22: 231-6.
18. Najman DM, Walenga JM, Fareed J, Pifarre R. Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery. Ann Thorac Surg 1993; 55: 662-6.
19. Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998; 116: 716-30.
20. Zabeeda D, Medalion B, Sverdlov M, et al. Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. Ann Thorac Surg 2002; 74: 733-8.
21. Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 1083-91.